Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gsk 3 inhibitor 1'

Search results for: 'gsk 3 inhibitor 1'

Items 251-260 of 358

Page
per page
  1. Zebularine
    A1915 Zebularine
     1 Citation
    Target: DNA Methyltransferases|Cytidine deaminases
    Summary: DNA methylation inhibitor
      insoluble in EtOH; ≥50.7 mg/mL
  2. NVP-BSK805 2HCl
    A4148 NVP-BSK805 2HCl
    Target: JAK
    Summary: JAK2 inhibitor
      ≥30.8 mg/mL
  3. Sal 003
    A4541 Sal 003
    Summary: Cellular phosphatase complex inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.15 mg/mL
  4. Pracinostat (SB939)
    A4095 Pracinostat (SB939)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Pan-HDAC inhibitor
      insoluble in H2O; ≥11.4 mg/mL
  5. BIX 01294
    A1909 BIX 01294
    Target: G9a
    Summary: G9a and GLP inhibitor
      ≥24.45 mg/mL
  6. Belinostat (PXD101)
    A4096 Belinostat (PXD101)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Hydroxamate-type HDAC inhibitor
      insoluble in H2O; ≥15.92 mg/mL
  7. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
  8. ENMD-2076 L-(+)-Tartaric acid
    A4129 ENMD-2076 L-(+)-Tartaric acid
    Summary: Aurora kinases inhibitor
      insoluble in EtOH; ≥175.8 mg/mL
  9. Rucaparib (AG-014699,PF-01367338)
    A4156 Rucaparib (AG-014699,PF-01367338)
    Summary: Potent PARP inhibitor
      ≥21.08 mg/mL
  10. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL

Items 251-260 of 358

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 34item
  2. Aurora Kinase 30item
  3. DNA Methyltransferase 6item
  4. HDAC 60item
  5. Histone Acetyltransferases 17item
  6. Histone Demethylases 24item
  7. Histone Methyltransferase 42item
  8. HIF 11item
  9. JAK 41item
  10. MBT Domains 1 item
  11. PARP 31item
  12. Pim 8item
  13. Protein Ser/Thr Phosphatases 31item
  14. RNA Polymerase 3item
  15. Sirtuin 15item
  16. Sphingosine Kinase-2 1 item
  17. Polycomb repressive complex 1 item
  18. SUMOylation 2item
  19. PAD 1 item
Specificity
  1. Selective 106item
Reversibility
  1. Reversible 7item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 34item
  3. PI3K 1 item
  4. Aurora Kinases 21item
  5. MDM2 1 item
  6. EZH2 3item
  7. Bromodomains 8item
  8. FLT3 5item
  9. PLK 1 item
  10. VEGFR 3item
  11. RET 1 item
  12. Hydrolase 1 item
  13. MEK 1 item
  14. DOT1L 3item
  15. FGFR 2item
  16. Nrf2 1 item
  17. Pim 3item
  18. Sir2-like Family Deacetylases (Sirtuins) 3item
  19. PP1 1 item
  20. PP2A 1 item
  21. Src 5item
  22. Trk Receptors 1 item
  23. STAT 2item
  24. EGFR 2item
  25. Hypoxia Inducible Factors (HIFs) 2item
  26. Tankyrases 1 item
  27. JAK 20item
  28. p300 1 item
  29. Syk 1 item
  30. EZH1 1 item
  31. TNKS 1 item
  32. Topoisomerases 1 item
  33. ErbB 1 item
  34. DNA Methyltransferases 4item
  35. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  36. SMYD2 1 item
  37. CREBBP 2item
  38. EP300 2item
  39. LRRK2 1 item
  40. PARP 8item
  41. ALK 1 item
  42. Bromodomain and Extra-Terminal motif (BET) 1 item
  43. phosphatases 1 item
  44. NAT10 1 item
  45. G9a 2item
  46. Hck 1 item
  47. SETD7 1 item
  48. Histone Demethylases 1 item
  49. MNK 1 item
  50. AChE 1 item
  51. Catechol O-Methyltransferase (COMT) 1 item
  52. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  53. Protein Arginine Methyltransferases 1 item
  54. Cytidine deaminases 1 item
  55. PP4 1 item
  56. c-RET 1 item
  57. VEGFR3/FLT4 1 item
  58. NTRK1/TRKA 1 item
  59. CSF-1R/c-Fms 1 item
  60. PTP 1 item
  61. Protein polybromo-1 1 item
  62. SMARCA4 1 item
  63. SMARCA2 1 item
  64. p53 2item
  65. HDAC 2item
  66. KDM 2item
  67. Histone Acetyltransferases (HATs) 2item
  68. Trx 1 item
  69. HIF-PH 1 item
  70. L3MBTL 1 item
  71. TYK2 2item
  72. MUSK 1 item
  73. MAP3K 1 item
  74. Lck 1 item
  75. p21 1 item
  76. 5-HT 1 item
  77. PHF 1 item
  78. FGR 1 item
  79. YES 1 item
  80. Fyn 1 item
  81. ARG 1 item
  82. LSD 1 item
  83. PRMT 1 item
  84. GLP 1 item
  85. SK 1 item
  86. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 120item
  2. Cell Experiments 100item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 9item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 19item
  6. Cancer 85item
  7. Castration-resistant Prostate Cancer 1 item
  8. Cervical Cancer 2item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Colon Cancer 11item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 5item
  13. Diabetes 1 item
  14. Diffuse Large B-cell Lymphoma 1 item
  15. Dyskinesia 1 item
  16. Epilepsy 1 item
  17. Friedreich's Ataxia 1 item
  18. Glioblastoma 2item
  19. Glioma 2item
  20. Hepatic Cancer 1 item
  21. Hepatocellular Carcinoma 1 item
  22. HIV 2item
  23. HIV Infections 2item
  24. Immunological Diseases 1 item
  25. Inflammatory Bowel Disease 1 item
  26. Inflammatory Diseases 3item
  27. Leukemia 7item
  28. Lung Cancer 6item
  29. Lymphoma 6item
  30. Melanoma 5item
  31. Mixed Lineage Leukemia 3item
  32. Multiple Myeloma 5item
  33. Myelofibrosis 1 item
  34. Myeloma 1 item
  35. Neuroblastoma 2item
  36. Neuronal Protection 1 item
  37. Non-small Cell Lung Cancer 5item
  38. Ovarian Cancer 5item
  39. Pancreatic Cancer 4item
  40. Prostate Cancer 12item
  41. Psoriasis 1 item
  42. Renal Cancer 1 item
  43. Renal Cell Carcinoma 2item
  44. Rheumatoid Arthritis 3item
  45. Thyroid Cancer 1 item